)
Visual
earnings real time
InMed Pharmaceuticals (INM) investor relations material
InMed Pharmaceuticals Life Sciences Virtual Investor Forum 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Life Sciences Virtual Investor Forum 2025 summary11 Dec, 2025
Strategic focus and leadership
Pipeline targets CB1 and CB2 receptors with proprietary small molecule drug candidates for Alzheimer's, ocular disease, and dermatology.
Leadership team is highly experienced in drug development and commercialization.
Two operating segments: drug development and BayMedica for commercializing rare cannabinoids.
Clean balance sheet with no debt and a small, efficient team.
Plans to expand team as programs advance to later stages.
Drug development programs
INM-901 for Alzheimer's is in preclinical testing, showing reduced neuroinflammation, neuroprotection, and improved cognition in animal models.
INM-089 targets dry age-related macular degeneration, demonstrating preservation and healing of retinal cells in animal studies.
INM-755, a cannabinol cream, completed phase two trials for chronic itch in epidermolysis bullosa, showing clinically meaningful improvement in 66% of patients.
Prioritization is given to INM-901 due to higher unmet need and promising data.
No-go criteria are based on preclinical study outcomes; both lead programs continue development.
Financial and partnership outlook
$9.3 million in cash as of September 30, providing about one year of runway.
Market cap is approximately $5.6 million with a small share float.
Actively seeking strategic partners to accelerate development and share costs, especially for INM-755 and preclinical assets.
Collaborates with academic experts globally for disease-specific research.
Key catalysts for 2026 include securing strategic partnerships and presenting new data at scientific conferences.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next InMed Pharmaceuticals earnings date
Q2 20265 Feb, 2026
Next InMed Pharmaceuticals earnings date
Q2 20265 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
InMed Pharmaceuticals Inc is a Canadian biotechnology company specializing in the research and development of rare cannabinoids. The company focuses on creating pharmaceutical and consumer health products derived from cannabinoid compounds using biosynthesis and chemical synthesis technologies. Its operations span proprietary drug development and manufacturing services. InMed Pharmaceuticals Inc is headquartered in Vancouver, Canada, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage